Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-11

FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for valacyclovir hydrochloride (generic valacyclovir) from Mylan Pharmaceuticals Inc., under ANDA078518.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir hydrochloride (valacyclovir hydrochloride)

Snippet

SUPPL AP for VALACYCLOVIR HYDROCHLORIDE (VALACYCLOVIR)